Home > News > Arch raises $400 million venture fund
December 10th, 2007
Arch raises $400 million venture fund
Arch Venture Partners, the 21-year-old venture capital firm whose Seattle area investments include Allozyne, Trubion Pharmaceuticals and VLST, has raised a $400 million venture fund.
It is the firm's seventh fund. The money will be invested in early-stage companies in the biotechnology, advanced materials, nanotechnology and semiconductor sectors.
Harris & Harris Group Issues Reminder for Shareholder Update Call on January 10, 2017 January 10th, 2017
Harris & Harris Group Announces a Proposed Strategic Restructuring December 20th, 2016
Harris & Harris Group Issues Letter to Shareholders and Information for Shareholder Call on Tuesday, November 15, 2016 November 14th, 2016
Harris & Harris Group Issues Business Update and Reports Financial Statements as of September 30, 2016 November 9th, 2016
A big nano boost for solar cells: Kyoto University and Osaka Gas effort doubles current efficiencies January 21st, 2017
A toolkit for transformable materials: How to design materials with reprogrammable shape and function January 20th, 2017
New research helps to meet the challenges of nanotechnology: Research helps to make the most of nanoscale catalytic effects for nanotechnology January 20th, 2017
Ultra-precise chip-scale sensor detects unprecedentedly small changes at the nanoscale January 20th, 2017